Trial site
Retina Group of Florida
- 9running trials
- 9closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Macular degeneration13 trials
- Diabetic eye disease4 trials
- Phase
- Phase 312 trials
- Phase 24 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Completed9 trials
- Active, not recruiting5 trials
- Recruiting3 trials
- Not yet recruiting1 trial
- Lead sponsor
- 4D Molecular Therapeutics3 trials
- Hoffmann-La Roche3 trials
- Janssen Research & Development, LLC2 trials
- Kodiak Sciences Inc2 trials
- Astellas Pharma Global Development, Inc.1 trial
- and 7 more
Running trials
Recruiting
A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME).
Active, not recruiting
4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Macular degeneration3 recruiting
- Diabetic eye disease1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026